454 related articles for article (PubMed ID: 26028353)
1. Update on the role of Interleukin 17 in rheumatologic autoimmune diseases.
Konya C; Paz Z; Apostolidis SA; Tsokos GC
Cytokine; 2015 Oct; 75(2):207-15. PubMed ID: 26028353
[TBL] [Abstract][Full Text] [Related]
2. The Role of IL-17 in the Human Immune System and Its Blockage as a Treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis.
Jaller Char JJ; Jaller JA; Waibel JS; Bhanusali DG; Bhanusali N
J Drugs Dermatol; 2018 May; 17(5):539-542. PubMed ID: 29742185
[TBL] [Abstract][Full Text] [Related]
3. Anti cytokine therapy in chronic inflammatory arthritis.
Thompson C; Davies R; Choy E
Cytokine; 2016 Oct; 86():92-99. PubMed ID: 27497159
[TBL] [Abstract][Full Text] [Related]
4. Secukinumab for rheumatology: development and its potential place in therapy.
Koenders MI; van den Berg WB
Drug Des Devel Ther; 2016; 10():2069-80. PubMed ID: 27445458
[TBL] [Abstract][Full Text] [Related]
5. Biologic Therapies for Autoimmune and Connective Tissue Diseases.
Wolfe RM; Ang DC
Immunol Allergy Clin North Am; 2017 May; 37(2):283-299. PubMed ID: 28366477
[TBL] [Abstract][Full Text] [Related]
6. Secukinumab: first global approval.
Sanford M; McKeage K
Drugs; 2015 Feb; 75(3):329-38. PubMed ID: 25648267
[TBL] [Abstract][Full Text] [Related]
7. The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases.
Toussirot E
Inflamm Allergy Drug Targets; 2012 Apr; 11(2):159-68. PubMed ID: 22280236
[TBL] [Abstract][Full Text] [Related]
8. Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis.
Kenna TJ; Davidson SI; Duan R; Bradbury LA; McFarlane J; Smith M; Weedon H; Street S; Thomas R; Thomas GP; Brown MA
Arthritis Rheum; 2012 May; 64(5):1420-9. PubMed ID: 22144400
[TBL] [Abstract][Full Text] [Related]
9. Increased CCR4 expression on circulating CD4(+) T cells in ankylosing spondylitis, rheumatoid arthritis and systemic lupus erythematosus.
Yang PT; Kasai H; Zhao LJ; Xiao WG; Tanabe F; Ito M
Clin Exp Immunol; 2004 Nov; 138(2):342-7. PubMed ID: 15498047
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-9 and T helper type 9 cells in rheumatic diseases.
Ciccia F; Guggino G; Ferrante A; Cipriani P; Giacomelli R; Triolo G
Clin Exp Immunol; 2016 Aug; 185(2):125-32. PubMed ID: 27159882
[TBL] [Abstract][Full Text] [Related]
11. [Biological therapy of arthritis and systemic autoimmune diseases].
Tamási L; Szekanecz Z
Orv Hetil; 2007 Apr; 148 Suppl 1():63-70. PubMed ID: 17430797
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-17 and innate immunity in infections and chronic inflammation.
Isailovic N; Daigo K; Mantovani A; Selmi C
J Autoimmun; 2015 Jun; 60():1-11. PubMed ID: 25998834
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of interleukin-17 in inflammation and autoimmune diseases.
Yan JW; Wang YJ; Peng WJ; Tao JH; Wan YN; Li BZ; Mei B; Chen B; Yao H; Yang GJ; Li XP; Ye DQ; Wang J
Expert Opin Ther Targets; 2014 Jan; 18(1):29-41. PubMed ID: 24147601
[TBL] [Abstract][Full Text] [Related]
14. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.
Williams RO; Paleolog E; Feldmann M
Curr Opin Pharmacol; 2007 Aug; 7(4):412-7. PubMed ID: 17627887
[TBL] [Abstract][Full Text] [Related]
15. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany.
Huscher D; Merkesdal S; Thiele K; Zeidler H; Schneider M; Zink A;
Ann Rheum Dis; 2006 Sep; 65(9):1175-83. PubMed ID: 16540552
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis.
Mease PJ
Curr Opin Rheumatol; 2015 Mar; 27(2):127-33. PubMed ID: 25599143
[TBL] [Abstract][Full Text] [Related]
17. Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases.
Siebert S; Tsoukas A; Robertson J; McInnes I
Pharmacol Rev; 2015; 67(2):280-309. PubMed ID: 25697599
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis.
Kirkham BW; Kavanaugh A; Reich K
Immunology; 2014 Feb; 141(2):133-42. PubMed ID: 23819583
[TBL] [Abstract][Full Text] [Related]
19. Th22 Cells Contribution in Immunopathogenesis of Rheumatic Diseases.
Azizi G; Simhag A; El Rouby NM; Mirshafiey A
Iran J Allergy Asthma Immunol; 2015 Jun; 14(3):246-54. PubMed ID: 26546892
[TBL] [Abstract][Full Text] [Related]
20. Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides.
Jandus C; Bioley G; Rivals JP; Dudler J; Speiser D; Romero P
Arthritis Rheum; 2008 Aug; 58(8):2307-17. PubMed ID: 18668556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]